Using genetic testing, a potential new face has been put on one of medicine's oldest, most commonly used and dreaded medications. Warfarin is an anticoagulant medication prescribed worldwide to ...
Improving accurate dosing of warfarin, a blood-thinning agent, is the goal of a new partnership between Metabolon Inc. and the Harvard-Partners Center for Genetics and Genomics (HPCGG). Although ...
Metabolomic profile will be assessed along with genetic information to optimize dosing. Metabolon and the Harvard-Partners Healthcare Center for Genetics and Genomics (HPCGG) are working together to ...
RESEARCH TRIANGLE PARK, N.C. & BOSTON--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, and the Harvard-Partners Center for Genetics and Genomics ...
Patients receiving warfarin require regular monitoring of the international normalized ratio (INR) and appropriate dosage adjustments in order to remain within the drug's narrow therapeutic range.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results